Skip to main content

sirolimus (Hyftor®)

 

Status: Excluded due to NICE appraisal

Product meets AWMSG exclusion criteria due to NICE appraisal ID6440: Sirolimus gel for treating facial angiofibroma from tuberous sclerosis complex in people 6 years and older (review of TA972)

Medicine details

Medicine name sirolimus (Hyftor®)
Formulation 2 mg/g gel
Reference number 4973
Indication

Treatment of facial angiofibroma associated with tuberous sclerosis complex in adults and paediatric patients aged 6 years and older.

Company Plusultra pharma
BNF chapter Skin
Submission type N/A
Status Excluded due to NICE appraisal
Date of issue 22/10/2024
NICE guidance

ID6440: Sirolimus gel for treating facial angiofibroma from tuberous sclerosis complex in people 6 years and older (review of TA972)

Follow AWTTC: